ItÃ¢ÂÂs All about Signals, Risk Management and How Important These Are?
|Garlapati S1* and Anireddy KR2|
|13R Biopharma, LLC 50 Dinsmore Ave, Framingham, MA, USA|
|2Vigilare Biopharma, Pvt. Ltd. Kukatpally, Hyderabad, India|
|*Corresponding Author :||Garlapati S
3R Biopharma, LLC 50 Dinsmore Ave
Framingham, MA, USA
Tel: 1 -914-486-1898
E-mail: [email protected]
|Received November 04, 2014; Accepted November 05, 2014; Published November 06, 2014|
|Citation: Garlapati S, Anireddy KR (2014) It’s All about Signals, Risk Management and How Important These Are? Adv Pharmacoepidemiol Drug Saf 3:e127. doi:10.4172/2167-1052.1000e127|
|Copyright: © 2014 Garlapati S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
Pharmacovigilance is the study that amplifies safety of drugs with the fundamental objective of complete abstain on the ADRs and timely identification/detection of new adverse drug reactions. The fundamental principle of the pharmacovigilance is to figure out and valuate the benefit and risk profile of the pharmacological activity and to increase the rational usage of drugs. Adverse Drug Reactions (ADR) are a major cause of patient morbidity and mortality. Spontaneous reporting of ADRs is found to be crucial in maintaining patient safety.